| Literature DB >> 33513793 |
Shupeng Wang1, Shaohua Jin1, Qinghai Shu1, Song Wu2.
Abstract
Bladder cancer is a significant public health concern and social burden due to its high recurrence risk. Intravesical drug instillation is the primary therapy for bladder cancer to prevent recurrence. However, the intravesical drug therapeutic effect is limited by bladder penetrating barriers. The inadequate intravesical treatment might cause the low drug concentration in lesions, resulting in a high recurrence/progression rate of bladder cancer. Many strategies to get drugs across bladder penetrating barriers have been developed to improve intravesical treatment, including physical and chemical methods. This review summarizes the classical and updated literature and presents insights into great therapeutic potential strategies to overcome bladder penetrating barriers for improving the intravesical treatment of bladder cancer.Entities:
Keywords: bladder cancer; bladder mucosa; bladder penetrating barriers; drug instillation; intravesical treatment; urothelium
Year: 2021 PMID: 33513793 DOI: 10.3390/pharmaceutics13020166
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321